Bandaram Pharma Packtech Management
Management criteria checks 1/4
Bandaram Pharma Packtech's CEO is Bandaram Reddy, appointed in Feb 2023, has a tenure of 1.83 years. total yearly compensation is ₹3.60M, comprised of 100% salary and 0% bonuses, including company stock and options. directly owns 39.38% of the company’s shares, worth ₹211.77M. The average tenure of the management team and the board of directors is 1.8 years and 2.8 years respectively.
Key information
Bandaram Reddy
Chief executive officer
₹3.6m
Total compensation
CEO salary percentage | 100.0% |
CEO tenure | 1.8yrs |
CEO ownership | 39.4% |
Management average tenure | 1.8yrs |
Board average tenure | 2.8yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | ₹16m |
Jun 30 2024 | n/a | n/a | ₹11m |
Mar 31 2024 | ₹4m | ₹4m | ₹9m |
Compensation vs Market: Bandaram's total compensation ($USD42.22K) is about average for companies of similar size in the Indian market ($USD42.16K).
Compensation vs Earnings: Insufficient data to compare Bandaram's compensation with company performance.
CEO
Bandaram Reddy (41 yo)
1.8yrs
Tenure
₹3,600,000
Compensation
Mr. Bandaram Deepak Reddy is Managing Director & Executive Director of Bandaram Pharma Packtech Limited since February 07, 2023 and serves as its an Executive Chairman of the Board since August 13, 2024. H...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD & Executive Chairman | 1.8yrs | ₹3.60m | 39.38% ₹ 211.8m | |
Chief Financial Officer | 2.8yrs | ₹300.00k | no data | |
Company Secretary & Compliance Officer | 1.3yrs | ₹525.00k | no data | |
Executive Vice President of Corporate Affairs | no data | no data | no data |
1.8yrs
Average Tenure
41yo
Average Age
Experienced Management: 524602's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
MD & Executive Chairman | 1.8yrs | ₹3.60m | 39.38% ₹ 211.8m | |
Non-Executive Director | 2.8yrs | no data | 15% ₹ 80.7m | |
Independent Director | 2.8yrs | no data | no data | |
Independent Director | 2.8yrs | no data | no data | |
Non-Executive Director | 2.8yrs | no data | 15% ₹ 80.7m | |
Independent Director | 1.3yrs | no data | no data | |
Independent Director | 1.2yrs | no data | no data | |
Independent Director | no data | no data | no data |
2.8yrs
Average Tenure
40.5yo
Average Age
Experienced Board: 524602's board of directors are not considered experienced ( 2.8 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/26 04:56 |
End of Day Share Price | 2024/12/26 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Bandaram Pharma Packtech Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|